Clinical Trial Update: Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID [Phase 3]

View source ↗

Summary

Phase 3 trial comparing esomeprazole with placebo for prevention of NSAID-associated gastric and duodenal ulcers; results completed and posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer

Drugs mentioned

• Esomeprazole (Esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Gastric Ulcer, Duodenal Ulcer | Phase 3 | Status: COMPLETED | Results posted: 2010-05-28